Urolithin A for Muscle Health: What Human Trials Show

Urolithin A is a compound produced by gut microbes from ellagitannins found in foods such as pomegranate. It is also sold as a supplement and is studied as a possible mitophagy-related intervention.

The topic is promising, but “rejuvenates mitochondria” and “extends your physical prime” are marketing phrases, not established outcomes for healthy lifters.

What mitophagy means

Mitophagy is the process by which cells identify and remove damaged mitochondria. Urolithin A can influence mitophagy-related pathways in preclinical work. That does not mean a capsule increases muscle size, reverses ageing, or improves every person’s recovery.

The route from a cellular pathway to a training outcome has several steps: the compound must reach the relevant tissue, change the intended biology, improve function, and do so safely. Human trials have to test those steps rather than assume them.

What human trials show

Randomized trials have studied Urolithin A in middle-aged and older adults over several months. Findings have included changes in selected mitochondrial or muscle-endurance measures, and one trial reported improvements in strength and exercise performance. These results are useful but population-specific. They do not establish an effect in young resistance-trained lifters, do not prove hypertrophy, and do not show that every formulation is equivalent.

The studies also use defined products and selected participants. A supplement label that says “mitochondrial support” is not evidence that it matches the trial intervention.

How to think about use

Urolithin A is optional and relatively low priority for a person whose main goal is strength or muscle. Creatine, adequate protein and energy, progressive resistance training, and sleep have more direct relevance.

If you consider a product, define the outcome in advance and assess cost, tolerance, product identity, medication context, and the length of the trial. Do not use it to justify training through unexplained fatigue or to replace evaluation for a medical problem.

Bottom line

Urolithin A has an interesting mechanism and some human evidence for selected muscle and mitochondrial outcomes in middle-aged or older adults. It is not yet a proven muscle-building or anti-aging shortcut for lifters, and mitophagy language should not be mistaken for a guarantee.

For a stronger foundation, read Creatine Monohydrate. For another supplement with a biomarker-to-performance evidence gap, see CoQ10 for Strength Athletes.

Related reading

• Creatine Monohydrate: The Science Behind the Most Researched Supplement
• CoQ10 for Strength Athletes: What the Evidence Shows

Applying this article

Keep a prospective log of the outcome you care about and change one supplement at a time. A change in a mitochondrial marker is not enough to continue a costly product if training performance does not improve.

Limits of the evidence

Trials are relatively short, use selected age groups and products, and measure different outcomes. Evidence in older adults cannot be assumed to predict hypertrophy in young trained lifters.

Sources

• Urolithin A and muscle endurance or mitochondrial health in older adults. Randomized trial; outcomes are population-specific.
• Urolithin A, muscle strength, exercise performance, and mitochondrial biomarkers. Randomized middle-aged-adult trial; product and population are specific.